supported by the PLAGH Innovation Funds,(Grant No.22QNFC080);the Sichuan Science and Technology Program(Grant No.2023ZYD0064 and 2023YFG0220);the Fundamental Research Funds for the Central Universities(Grant No.YJ202242);the Research Funding from West China School/Hospital of Stomatology, Sichuan University(Grant No.QDJF2022-2);National Undergraduate Training Program for Innovation(Grant No.C2024129736)。
Objective Cancer remains a significant global health challenge, necessitating the development of effective treatment approaches. Developing synergistic therapy can provide a highly promising strategy for anti-cancer t...
Supported by the National Natural Science Foundation of China(No.81904118);Hospital Capability Enhancement Project of Xiyuan Hospital,China Academy of Chinese Medical Sciences(No.XYZX0201-09);the Special Programme for the Cultivation of Outstanding Young Scientific and Technological Talents of the China Academy of Chinese Medical Sciences(No.ZZ17-YQ-005)。
Objective:To explore the molecular mechanism of Shenmai Injection(SMI)against doxorubicin(DOX)induced cardiomyocyte apoptosis.Methods:A total of 40 specific pathogen-free(SPF)male Sprague Dawley(SD)male rats were divi...
supported by grants from the National Natural Science Foundation of China(No.82173911,81973406,82373970);Hunan Provincial Natural Science Foundation of China(No.2023JJ30761,2023JJ30802);Scientific Research Project of Hunan Provincial Health and Family Planning Commission(China)(No.202113050843);Research Project established by Chinese Pharmaceutical Association Hospital Pharmacy Department(No.CPA-Z05-ZC-2021-002);Changsha Scienceand Technology Project(China)(No.kq2004137);Chinese Anti-Cancer Association HER2 target Chinese Research Fund(No.CORP-239-S5).
Doxorubicin(Dox),an anthracycline chemotherapy drug,is used extensively in cancer chemotherapy and has been studied in depth in relation to cancers including leukemia,small-cell lung cancer,and ovarian cancer.1 Howeve...
This work was supported by the National Natural Science Foundation of China(82130011,92249301,and RFIS82250710173).
Doxorubicin(DOx),a common chemotherapeutic agent in cancer therapy,is accompanied by pronounced cardiotoxicity.Ferroptosis has been implicated in the pathogenesis and therapeutics of DOX-induced cardiotoxicity(DIC).As...
supported by the National Key Research and Development Program of China(No.2022YFE0107800);National Natural Science Foundation of China(Nos.82373206,and 82073332);Zhejiang Provincial Natural Science Foundation of China(No.LHDMZ24H300002)。
Traditionally,hyaluronic acid has been widely used for drug delivery,but the current application bottleneck is that hyaluronic acid is hydrophilic and electronegative,which makes it difficult to carry hydrophobic drug...
supported by the China National Postdoctoral Program for Innovative Talents (BX2021364);the China Postdoctoral Science Foundation (2021M703525).
α-Lactalbumin(a-lac),a natural food-sourced protein,exhibits high biocompatibility as delivery systems for small bioactive molecules or RNA.However,their potential clinical application as a delivery system is greatly...
National Key Research and Development Program of China,Grant/Award Number:2022YFA1105304;National Natural Science Foundation of China,Grant/Award Numbers:32201088,82273954;Natural Science Foundation of Jiangsu Province,Grant/Award Number:BK20210010;Fundings for Clinical Trials from the Affiliated Drum Tower Hospital,Medical School of Nanjing University,Grant/Award Number:2022-LCYJ-MS-16。
Several therapeutic drugs including heptamethine cyanine dye(IR-780),doxorubicin(DOX),and others have exhibited positive outcomes in the treatment of multiple myeloma(MM).However,curing MM is still hampered by undesir...
supported by the National Natural Science Foundation of China(Nos.32222046,82172630)。
Lymphoma is a hematological malignancy with an increasing mortality rate.Nevertheless,the treatment strategy against lymphoma remains limited.Doxorubicin(DOX)is a broad-spectrum anti-tumor chemotherapeutic drug,the cl...
supported by grants of the National Natural Science Foundation of China(Nos.82000411,82030051,82241203,81920108003 and 81970366);State Key R&D Program of China(2021YFF0501403);Key R&D Program of Shandong Province(2021SFGC0503,2021ZLGX02,2021ZDSYS05,2020ZLYS05);Shandong Provincial Natural Science Foundation(ZR2020QH023);the Taishan Scholars Program of Shandong Province(C.Z.);China Postdoctoral Science Foundation(2023M742124);Postdoctoral Innovation Talents Support Program(BX20230210).
The pathogenesis of doxorubicin-induced cardiomyopathy remains unclear.This study was carried out to test our hypothesis that ADAM17 aggravates cardiomyocyte apoptosis induced by doxorubicin and inhibition of ADAM17 m...
supported by the National Key R&D Program of China(No.2019YFA0110600);the National Natural Science Foundation of China(Nos.82370929 and 81970916);the Sichuan Science and Technology Program(Nos.2022NSFSC0002 and 2023YFG022);Sichuan Province Youth Science and Technology Innovation Team(No.2022JDTD0021);Research and Develop Program,West China Hospital of Stomatology Sichuan University(No.RD03202302);the Research Funding from West China School/Hospital of Stomatology Sichuan University(No.QDJF2022-2)。
Triple-negative breast cancer,due to its aggressive nature and lack of targeted treatment,faces serious challenges in breast cancer treatment.Conventional therapies,such as chemotherapy,are encumbered by a range of li...